Articles with public access mandates - Jessica Lilian BellLearn more
Not available anywhere: 2
The critical role of RNA m6A methylation in cancer
Q Lan, PY Liu, J Haase, JL Bell, S Hüttelmaier, T Liu
Cancer research 79 (7), 1285-1292, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance
Q Lan, PY Liu, JL Bell, JY Wang, S Hüttelmaier, XD Zhang, L Zhang, T Liu
Cancer research 81 (13), 3431-3440, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
Available somewhere: 19
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
JL Bell, K Wächter, B Mühleck, N Pazaitis, M Köhn, M Lederer, ...
Cellular and molecular life sciences 70, 2657-2675, 2013
Mandates: German Research Foundation
IGF2BP1 Harbors Prognostic Significance by Gene Gain and Diverse Expression in Neuroblastoma
JL Bell, R Turlapati, T Liu, JH Schulte, S Hüttelmaier
Journal of Clinical Oncology 33 (11), 1285-1293, 2015
Mandates: Australian Research Council, National Health and Medical Research Council …
Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression
PY Liu, D Erriquez, GM Marshall, AE Tee, P Polly, M Wong, B Liu, JL Bell, ...
JNCI: Journal of the National Cancer Institute 106 (7), dju113, 2014
Mandates: Australian Research Council, National Health and Medical Research Council …
WDR5 supports an N-Myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma
Y Sun, JL Bell, D Carter, S Gherardi, RC Poulos, G Milazzo, JWH Wong, ...
Cancer research 75 (23), 5143-5154, 2015
Mandates: Australian Research Council, National Health and Medical Research Council …
The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription
M Wong, AEL Tee, G Milazzo, JL Bell, RC Poulos, B Atmadibrata, Y Sun, ...
Cancer research 77 (9), 2522-2533, 2017
Mandates: Australian Research Council, National Health and Medical Research Council …
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma
M Wong, Y Sun, Z Xi, G Milazzo, RC Poulos, C Bartenhagen, JL Bell, ...
Nature Communications 10 (1), 3319, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization
JL Bell, A Malyukova, M Kavallaris, GM Marshall, BB Cheung
Cell cycle 12 (6), 889-898, 2013
Mandates: National Health and Medical Research Council, Australia
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro
BB Cheung, J Koach, O Tan, P Kim, JL Bell, C D'andreti, S Sutton, ...
The Journal of pathology 226 (3), 451-462, 2012
Mandates: Cancer Research UK
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
J Haase, D Misiak, M Bauer, N Pazaitis, J Braun, R Pötschke, A Mensch, ...
Modern Pathology 34 (1), 32-41, 2021
Mandates: German Research Foundation
Drugging MYCN oncogenic signaling through the MYCN-PA2G4 binding interface
J Koach, JK Holien, H Massudi, DR Carter, OC Ciampa, M Herath, T Lim, ...
Cancer research 79 (21), 5652-5667, 2019
Mandates: National Health and Medical Research Council, Australia
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
S Hagemann, D Misiak, JL Bell, T Fuchs, MI Lederer, N Bley, M Hämmerle, ...
Molecular Cancer 22 (1), 88, 2023
Mandates: German Research Foundation
The MicroRNA landscape of MYCN-amplified neuroblastoma
D Misiak, S Hagemann, JL Bell, B Busch, M Lederer, N Bley, JH Schulte, ...
Frontiers in Oncology 11, 647737, 2021
Mandates: German Research Foundation
Identification of RNA-binding proteins as targetable putative oncogenes in neuroblastoma
JL Bell, S Hagemann, JK Holien, T Liu, Z Nagy, JH Schulte, D Misiak, ...
International Journal of Molecular Sciences 21 (14), 5098, 2020
Mandates: National Health and Medical Research Council, Australia
Targeting hdacs in pancreatic neuroendocrine tumor models
RL Schmitz, J Weissbach, J Kleilein, J Bell, S Hüttelmaier, F Viol, ...
Cells 10 (6), 1408, 2021
Mandates: German Research Foundation
Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer
EM Poursani, D Mercatelli, P Raninga, JL Bell, F Saletta, FV Kohane, ...
Cell & Bioscience 13 (1), 132, 2023
Mandates: Australian Research Council, National Health and Medical Research Council …
Hyaluronic acid within self-assembling nanoparticles: endless possibilities for targeted cancer therapy
M Curcio, O Vittorio, JL Bell, F Iemma, FP Nicoletta, G Cirillo
Nanomaterials 12 (16), 2851, 2022
Mandates: Government of Italy
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
JRC Rouaen, A Salerno, T Shai-Hee, JE Murray, G Castrogiovanni, ...
Nature Communications 15 (1), 1-20, 2024
Mandates: National Health and Medical Research Council, Australia
Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a …
KM Allan, MA Astore, E Kardia, SL Wong, LK Fawcett, JL Bell, S Visser, ...
Frontiers in Molecular Biosciences 10, 1148501, 2023
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program